Related Experiment Video
Updated: Jul 17, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis
M Kuwana1, J Kaburaki, T Mimori
1Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Abstract:
We have identified a novel autoantibody reactive with all three classes of RNA polymerases, well-characterized nuclear enzymes, in sera from patients with systemic sclerosis (SSc). After incubation with [35S]methionine-labeled HeLa cell extracts, 14 of 275 SSc sera immunoprecipitated 12 or 14 proteins with similar molecular weights as those of several subunit proteins of eukaryotic RNA polymerases I, II, and III. Purified IgG from these two types of sera inhibited RNA transcription catalyzed by RNA polymerases I, II, and III in vitro. Immunoblot analysis using RNA polymerase-enriched fraction showed that the majority of these sera reacted with 42- or 25-kD protein. Anti-RNA polymerase antibody was highly specific to SSc, especially to diffuse cutaneous SSc. Clinical features associated with this antibody included a high frequency of heart and kidney involvement and a poor survival rate at 5 yr after first visit. These findings indicate that the autoantibody to three classes of RNA polymerases is a new marker for a unique subset of diffuse cutaneous SSc.
Insights
Researchers found a new autoantibody targeting all three RNA polymerases in systemic sclerosis (SSc) patients. This anti-RNA polymerase antibody is specific to SSc, particularly diffuse cutaneous SSc, and indicates a poor prognosis.
Area of Science:
- Immunology
- Molecular Biology
- Rheumatology
Background:
- Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis.
- Nuclear autoantibodies are common in SSc, but novel targets are continually being identified.
- RNA polymerases are essential enzymes for gene transcription.
Purpose of the Study:
- To identify novel autoantibodies in patients with systemic sclerosis (SSc).
- To characterize the reactivity and clinical significance of an autoantibody targeting RNA polymerases in SSc.
Main Methods:
- Sera from SSc patients were used for immunoprecipitation assays with labeled cell extracts.
- Inhibition assays were performed to assess the effect of purified IgG on RNA transcription.
- Immunoblot analysis was conducted using RNA polymerase-enriched fractions.
Main Results:
- A novel autoantibody reactive with all three classes of RNA polymerases (I, II, and III) was identified in 14 out of 275 SSc sera.
- The autoantibody inhibited RNA transcription in vitro.
- Anti-RNA polymerase antibody was highly specific for SSc, particularly diffuse cutaneous SSc, and associated with heart/kidney involvement and poor survival.
Conclusions:
- A novel autoantibody targeting RNA polymerases is identified in a subset of SSc patients.
- This autoantibody serves as a potential biomarker for a unique subset of diffuse cutaneous SSc.
- The presence of this antibody is linked to significant organ involvement and reduced survival rates.
Related Concept Videos
Cross-reactivity
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Hypersensitivity Reactions: Immune-Complex Reactions

